Sarepta Therapeutics (SRPT) to Join S&P MidCap 400

Sarepta Therapeutics (NASDAQ: SRPT) will replace Shockwave Medical Inc. (NASD: SWAV) in the S&P MidCap 400 effective prior to the opening of trading on Monday, June 3. S&P 500 constituent Johnson & Johnson (NYSE: JNJ) is acquiring Shockwave Medical in a deal expected to be completed soon pending final closing conditions.

You May Also Be Interested In

• Reddit (RDDT) added to S&P 500
• CleanCore Solutions to rename itself Zone Frontier Inc. on Aug. 31
• Paramount Skydance clears global regulators for WBD deal, faces state AG suit